International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel

Study ID
NCT02051868

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

InterAACT

Trial Summary

Anal cancer is a relatively uncommon disease and there is currently no standard chemotherapy treatment for patients with inoperable locally recurrent or metastatic disease. The aim of this phase II study is compare two well known and largely used chemotherapy regimens - Cisplatin plus 5-fluorouracil vs Carboplatin plus Paclitaxel. The result of this study will set a standard of care for this disease and provide useful information for future Phase III trials.

More informations

Trial Starting Date

Dec 31,2013

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit